In This Section      
 

Research Trials: Cardiovascular

For more information, please contact Suburban Hospital Cardiovascular Research:
Ann Greenberg, RN: 301-896-2473
Philip Maglo: 301-896-3060
Sarah Lowe: 301-896-7576

TopicStudy NamePrincipal Investigator
CardiologyA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome
Learn more
Gregory Kumkumian, M.D.
CardiologyCare Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure - CONNECT-HF
Learn more
Gregory Kumkumian, M.D.
CardiologyRandomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy system in Patients with Post Myocardial Infarction Heart Failure (CardiAMP Heart Failure Trial)
Learn more
Gregory Kumkumian, M.D.
CardiologyA Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency
Learn more
Gregory Kumkumian, M.D.
Cardiac SurgeryTranscatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement.
Learn More
Jon Resar, M.D.
Michael Siegenthaler, M.D.
CardiologyA phase III, double‐blind, randomized placebo‐controlled study to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in a genetically defined population with a recent Acute Coronary Syndrome (ACS): The dal-­GenE trial.
Learn More
Gregory Kumkumian, M.D.
CardiologyUtilization of Ticagrelor in the Upstream Setting for A4:D9-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry.
Learn More
Gregory Kumkumian, M.D.
CardiologyA multi-center, randomized, double-blind, active-controlled, parallel- group Phase 3 study to evaluate the efficacy and safety of LCZ696 compared to ramipril on morbidity and mortality in high risk patients following an acute myocardial infarction (Paradise)
Learn More
Gregory Kumkumian, M.D.
Cardiac SurgeryA Multicenter, Prospective, Parallel-Group, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study of BB3 to Assess the Safety and Efficacy of BB3 in Patients Developing Acute Kidney Injury after Cardiac Surgery
Learn More
Thomas Matthew, M.D.
CardiologyAn Expanded Evaluation of the Safety of Clinically Indicated Magnetic Resonance Imaging (MRI) in Patients with Pacemakers and Implanted Cardioverter Defibrillators
Learn More
Henry Halperin, M.D.
Edward Healy, M.D.